The drug maker bought the company for $ 625 million upfront in late 2011 — and it's been a pretty good performer, bringing in about $ 100 million in annual sales. (fortune.com)
Dividend investors hope to avoid dividend cuts by buying companies with a history of consistently paying and increasing dividends. (mindfullyinvesting.com)
D is looking at buying a company at a cheap price, but this company has several lawsuits against it. (dividendmonk.com)